Author
Tatiana Taylor Salisbury
Other affiliations: University of Oxford, University of London, University College London
Bio: Tatiana Taylor Salisbury is an academic researcher from King's College London. The author has contributed to research in topics: Mental health & Psychological intervention. The author has an hindex of 10, co-authored 29 publications receiving 880 citations. Previous affiliations of Tatiana Taylor Salisbury include University of Oxford & University of London.
Papers
More filters
University of Ibadan1, University of Washington2, George Washington University3, College of Health Sciences, Bahrain4, King's College London5, Harvard University6, Health Services Academy7, University of Liverpool8, University of Sussex9, Michigan State University10, Kathmandu11, Oswaldo Cruz Foundation12, Pravara Institute of Medical Sciences13, University of KwaZulu-Natal14, University of the Free State15, Centre for Mental Health16
TL;DR: In this article, the authors examined the mental health implications of the COVID-19 pandemic in low-income and middle-income countries (LMICs) in four parts: the emerging literature on the impact of the pandemic on mental health, which shows high rates of psychological distress and early warning signs of an increase in mental health disorders.
359 citations
TL;DR: There was a significant treatment effect for CBT-based psychotherapy compared to TAU at final follow-up in terms of fewer participants repeating SH, but for interventions typically delivered to individuals with a history of multiple episodes of SH/probable personality disorder, group-based emotion-regulation psychotherapy and mentalisation were associated with significantly reduced repetition.
Abstract: Background: Self-harm (SH; intentional self-poisoning or self-injury) is common, often repeated, and associated with suicide. This is an update of a broader Cochrane review first published in 1998, previously updated in 1999, and now split into three separate reviews. This review focuses on psychosocial interventions in adults who engage in self-harm.
Objectives: To assess the effects of specific psychosocial treatments versus treatment as usual, enhanced usual care or other forms of psychological therapy, in adults following SH.
Search methods: The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) trials coordinator searched the CCDAN Clinical Trials Register (to 29 April 2015). This register includes relevant randomised controlled trials (RCTs) from: the Cochrane Library (all years), MEDLINE (1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date).
Selection criteria: We included RCTs comparing psychosocial treatments with treatment as usual (TAU), enhanced usual care (EUC) or alternative treatments in adults with a recent (within six months) episode of SH resulting in presentation to clinical services.
Data collection and analysis: We used Cochrane's standard methodological procedures.
230 citations
TL;DR: This is an update of a broader Cochrane review on psychosocial and pharmacological treatments for deliberate SH and finds that mentalisation therapy was associated with fewer adolescents scoring above the cut-off for repetition of SH based on the Risk-Taking and Self-Harm Inventory 12 months post-intervention.
Abstract: Self-harm (SH; intentional self-poisoning or self-injury) is common in children and adolescents, often repeated, and strongly associated with suicide. This is an update of a broader Cochrane review on psychosocial and pharmacological treatments for SH published in 1998 and updated in 1999. We have
215 citations
TL;DR: A Cochrane systematic review and meta-analysis of the effectiveness of psychosocial interventions for self-harm in adults found CBT seems to be effective in patients after self- Harm, and there were few trials of other promising interventions, precluding firm conclusions as to their effectiveness.
162 citations
TL;DR: The limited evidence base suggests that peers may have a small additional impact on patient’s outcomes, in comparison to standard psychiatric care in high-income settings.
Abstract: Purpose
To evaluate the effectiveness of peer-delivered interventions in improving clinical and psychosocial outcomes among individuals with severe mental illness (SMI) or depression.
155 citations
Cited by
More filters
Uppsala University1, Karolinska Institutet2, University of Glasgow3, University College London4, University of Oxford5, King's College London6, University of Exeter7, Black Dog Institute8, University of California, Irvine9, University of Cambridge10, Swansea University11, Guy's and St Thomas' NHS Foundation Trust12, UCL Institute of Child Health13, St George's, University of London14, Emory University15, University of Bristol16, Academy of Medical Sciences, United Kingdom17
TL;DR: There is an urgent need for research to address how mental health consequences for vulnerable groups can be mitigated under pandemic conditions, and on the impact of repeated media consumption and health messaging around COVID-19.
3,909 citations
TL;DR: In this paper, the authors conducted a systematic review of data reporting the prevalence of major depressive disorder and anxiety disorders during the COVID-19 pandemic and published between Jan 1, 2020, and Jan 29, 2021.
1,582 citations
TL;DR: It is proposed that defeat and entrapment drive the emergence of suicidal ideation and that a group of factors, entitled volitional moderators (VMs), govern the transition from suicidal Ideation to suicidal behaviour.
Abstract: Suicide is a major public health concern accounting for 800 000 deaths globally each year. Although there have been many advances in understanding suicide risk in recent decades, our ability to pre...
587 citations
TL;DR: First-line psychological treatment recommendations for acute MDD include cognitive-behavioural therapy (CBT), interpersonal therapy (IPT), and behavioural activation (BA), and combined treatment with antidepressant treatment is recommended where feasible.
Abstract: Background:The Canadian Network for Mood and Anxiety Treatments (CANMAT) has revised its 2009 guidelines for the management of major depressive disorder (MDD) in adults by updating the evidence and recommendations. The target audiences for these 2016 guidelines are psychiatrists and other mental health professionals.Methods:Using the question-answer format, we conducted a systematic literature search focusing on systematic reviews and meta-analyses. Evidence was graded using CANMAT-defined criteria for level of evidence. Recommendations for lines of treatment were based on the quality of evidence and clinical expert consensus. “Psychological Treatments” is the second of six sections of the 2016 guidelines.Results:Evidence-informed responses were developed for 25 questions under 5 broad categories: 1) patient characteristics relevant to using psychological interventions; 2) therapist and health system characteristics associated with optimizing outcomes; 3) descriptions of major psychotherapies and their ef...
463 citations